Serum Progesterone Hormone Level and Threatened Miscarriage with Its Predictive Value for Viability

Shilan Muhtasam  Ahmed; Trefa Yousuf  Mutalib

doi:10.56056/409

Authors

Shilan Muhtasam Ahmed MBChB, KHCMS/Obstetrics and Gynecology , Erbil Maternity Teaching Hospital, Erbil, Kurdistan Region, Iraq
Trefa Yousuf Mutalib MBChB, FICOG, Consultant Obstetrician and Gynecologist, Erbil Maternity Teaching Hospital, Erbil, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.56056/409

Keywords:

Early pregnancy, Fetal viability, Outpatients, Serum progesterone, Threatened miscarriage

Abstract

Background and objectives: Serum progesterone hormone is essential for pregnancy development and progression. Thus, this study aimed to assess the level of serum progesterone in normal pregnancy and threatened miscarriage with its predictive value for viability.

Methods: This case-control study was held in outpatient clinics in the Emergency Departments of Erbil Maternity Teaching Hospital, Erbil, Iraq, from the 1^st June 2022 to 31^st May 2023 on 75 pregnant women with threatened miscarriages and 75 healthy pregnant women as controls. Diagnosis of threatened miscarriage was made through clinical features, investigations and ultrasonography. Then, the blood samples were collected to assess the serum progesterone level as a predictor for threatened miscarriage and viability of early pregnancy.

Results: Most participants (44%) were young (20-29 years old), had low economic status, gave birth to 1-3 children and had a gestational age of >9.0 weeks with no significant difference between both groups (p>0.05). A highly significant association (p<0.001) was observed between pregnant women with threatened miscarriage and non-viability of fetuses. The mean serum progesterone level was obviously decreased in females with threatened miscarriage. The mean serum progesterone hormone level of 20.5 nmol/L was a significant predictor of threatened miscarriage with acceptable validity findings. The mean serum progesterone hormone level of 11.8 nmol/L was a significant predictor of non-viability in pregnant women with threatened miscarriage and acceptable validity findings.

Conclusions: The serum progesterone level is an appropriate predictor of threatened miscarriage and fetal viability in early pregnancy.

Downloads

Download data is not yet available.

References

1. McLindon LA, James G, Beckmann MM, Bertolone J, Mahomed K, Vane M, et al. Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial. Hum Reprod 2023; 38(4):560-568.

2. Nepyivoda OM, Ryvak TB. Threatened miscarriage and pregnancy loss: contemporary aspects of the problem. Wiad Lek 2020; 73(5):1021-1027.

3. Kouk LJ, Neo GH, Malhotra R, Allen JC, Beh ST, Tan TC, et al. A prospective study of risk factors for first-trimester miscarriage in Asian women with threatened miscarriage. Singapore Med J 2013; 54(8):425–431.

4. Lek SM, Ku CW, Allen JC Jr, Malhotra R, Tan NS, Østbye T, et al. Validation of serum progesterone <35 nmol/L as a predictor of miscarriage among women with threatened miscarriage. BMC Pregnancy Childbirth 2017; 17(1):78-84.

5. Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The psychological impact of early pregnancy loss. Hum Reprod Update 2018; 24(6):731-749.

6. Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriages of unclear aetiology. Cochrane Database Syst Rev 2019; 2019:CD003511.

7. Arck PC, Rucke M, Rose M, Szekeres-Bartho J, Douglas AJ, Pritsch M, et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online 2008; 17(1):101–113.

8. Pillai RN, Konje JC, Tincello DG, Potdar N. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. Hum Reprod Update 2016; 22(2):228–239.

9. Salazar EL, Calzada L. The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol 2007; 23:222–225.

10. Arck PC, Rücke M, Rose M, Szekeres-Bartho J, Douglas AJ, Pritsch M, et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online 2008; 17:101–113.

11. Duan L, Yan D, Zeng W, Yang X, Wei Q. Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage. Arch Gynecol Obstet 2011; 283:431–435.

12. Tan TC, Ku CW, Kwek LK, Lee KW, Zhang X, Allen JC Jr, et al. A novel approach using serum progesterone as a triage to guide management of patients with threatened miscarriage: a prospective cohort study. Sci Rep 2020; 10(1):9153.

13. Ku CW, Allen JC Jr, Lek SM, Chia ML, Tan NS, Tan TC. Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13-weeks’ gestation: a prospective cohort study. BMC Pregnancy Childbirth 2018; 18(1):360-365.

14. Ku CW, Allen JC Jr, Malhotra R, Chong HC, Tan NS, Østbye T, et al. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage? Gynecol Endocrinol 2015; 31(8):647-651.

15. Akpan UB, Akpanika CJ, Asibong U, Arogundade K, Nwagbata AE, Etuk S. The Influence of Threatened Miscarriage on Pregnancy Outcomes: A Retrospective Cohort Study in a Nigerian Tertiary Hospital. Cureus 2022; 14(11): e31734.

16. Coffey CH, Casper LM, Reno EM, Casper SJ, Hillis E, Klein DA, et al. First-Trimester Pregnancy: Considerations for Wilderness and Remote Travel. Wilderness Environ Med 2023; 34(2):201-210.

17. Ahmed SR, El-Sammani Mel-K, Al-Sheeha MA, Aitallah AS, Jabin Khan F, Ahmed SR. Pregnancy outcome in women with threatened miscarriage: a year study. Mater Sociomed 2012; 24(1):26-28.

18. Saeed MS, Mohammed BN, Ali SH. Ultrasonic assessment of the first trimester vaginal bleeding in Duhok city/Kurdistan region of Iraq. J Duhok University 2022; 25(1): 113-123.

19. Kant RH, Ara S, Lone AI, Gupta S. Evaluation of outcome of pregnancy in threatened abortion by serum progesterone levels. Int J Reprod Contracept Obstet Gynecol 2015; 4:1313-1318.

20. Khosho EZ, Aiub MM, Adnan S. The value of early pregnancy single serum progesterone measurement about first-trimester viability. Thi-Qar Med J 2011; 5 (2): 133-141.

21. Bucuri CE, Ciortea R, Malutan AM, Berceanu C, Rada MP, Mihu D. Progesterone's Serum Level and a New Ultrasonographic Parameter in the First Trimester Pregnancy - Prognostic Factors for Embryonic Demise. Rev Bras Ginecol Obstet 2019; 41(9):525-530.

22. Blavier F, Blockeel C, Cools W, Faron G, Santos-Ribeiro S, Breugelmans M, et al. Serum progesterone levels could predict diagnosis, completion and complications of miscarriage. J Gynecol Obstet Hum Reprod 2020; 49(5):101721.

23. Muttalib TY. Use of single serum progesterone level measurement as a predictor of fetal viability during the first trimester. Zanco J Med Sci 2018; 22(2): 180–185.